BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 26433839)

  • 21. Characteristics of cutaneous lymphomas in Osaka, Japan (1988-1999) based on the European Organization for Research and Treatment of Cancer classification.
    Nagasawa T; Miwa H; Nakatsuka S; Itami S; Yoshikawa K; Aozasa K
    Am J Dermatopathol; 2000 Dec; 22(6):510-4. PubMed ID: 11190442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas.
    Dommann SN; Dommann-Scherrer CC; Ziegler T; Meyer J; Trüeb RM; Kündig T; Panizzon R; Burg G
    Am J Dermatopathol; 1997 Aug; 19(4):391-5. PubMed ID: 9261475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug resistance related proteins in primary cutaneous lymphomas.
    van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
    Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region.
    Pileri A; Morsia E; Zengarini C; Torre E; Goteri G; Quaglino P; Pimpinelli N; Paulli M; Pileri SA; Zinzani PL; Rupoli S
    Eur J Dermatol; 2023 Aug; 33(4):360-367. PubMed ID: 37823487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of primary cutaneous T-cell lymphomas.
    Willemze R; Beljaards RC; Meijer CJ
    Histopathology; 1994 May; 24(5):405-15. PubMed ID: 8088712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
    Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.
    Glusac EJ; Shapiro PE; McNiff JM
    Dermatol Clin; 1999 Jul; 17(3):601-14, ix. PubMed ID: 10410861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous pseudolymphomas: classification and differential diagnosis.
    Rijlaarsdam JU; Willemze R
    Semin Dermatol; 1994 Sep; 13(3):187-96. PubMed ID: 7986687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
    Garatti SA; Roscetti E; Trecca D; Fracchiolla NS; Neri A; Berti E
    Recent Results Cancer Res; 1995; 139():249-61. PubMed ID: 7597296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
    Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
    Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.
    Jiang TT; Cao S; Kruglov O; Virmani A; Geskin LJ; Falo LD; Akilov OE
    J Invest Dermatol; 2024 May; 144(5):1088-1098. PubMed ID: 38036289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycosis fungoides: cutaneous T-cell lymphoma.
    Zaim MT; Grinkemeyer MD
    Am Fam Physician; 1991 May; 43(5):1703-7. PubMed ID: 2021105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.
    Querfeld C; Rosen ST; Kuzel TM; Guitart J
    Semin Cutan Med Surg; 2003 Sep; 22(3):150-61. PubMed ID: 14649582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series.
    Tang H; Matsumoto N; Foss F; Xu M; Ahmed A
    Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e405-e410. PubMed ID: 37659965
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.